Astellas Pharma

Astellas Pharma is a shining star in the Japanese pharmaceuticals market. One of the largest prescription drug companies in Japan, the company's main products include gastritis treatment Gaster, hypertension therapy Micardis, prostate enlargement treatment Harnal, organ transplant immunosuppressant Prograf, and cholesterol drug Lipitor (sold in Japan via an agreement with Pfizer). Astellas' products (including those under development) include cardiovascular, central nervous system, oncology, metabolic, infectious disease, inflammation/immunology, gastroenterology, and urology therapies. The company markets its products to health care professionals and consumers in global markets.